Résumé:
In recent years considerable progress has been made in order to guarantee maximum
security for the transfused. However, a residual risk remains, that of contracting a viral
disease by transfusion, despite donor selection measures. The risk occurs when the donor is in
the seroconversion phase, a time when biological markers of viral pathology are undetectable
by routine serologic diagnostic methods.
The results obtained show that in a population of 96 hemodialysis recipients the percentages
were: HIV0%; HBs25% .HCV.6%. TPHA .33% in men compared to HIV0%; HBs75%
.HCV.67%. TPHA.3% in women. Nevertheless, these results show that the study population
was infected with syphilis (4%), HCV (19%), HBs (4%) and HIV (0%). Having an effective
health system for the detection of the disease transmissible by the blood is a good thing, the
organization of this system for a preventive fight and a psychological support to the patients
whatever the results of the test, without forgetting that this
Last must be individualized because there is not a standard method that would be suitable
in all situations.
